Dermatology practice succession planning involves navigating cosmetic-medical revenue mix considerations, active private equity acquisition activity in the cosmetic dermatology segment, methodology specifically calibrated to dermatology economics, and multi-year preparation horizons that align with the operational changes that improve transition outcomes. This article walks through how dermatology practice owners approach succession planning in the current consolidation landscape.
Why Dermatology Succession Planning Requires Specific Attention
Dermatology succession planning operates with several specific characteristics that distinguish it from general practice succession. The cosmetic-medical revenue split creates valuation complexity; active consolidator activity in cosmetic dermatology has reshaped multiples and transition expectations; medical dermatology operates with different buyer dynamics than cosmetic-heavy practices.
The structural distinctions matter because they shape every aspect of succession planning:
- Buyer category availability — cosmetic-heavy practices attract substantial consolidator interest; medical-only practices face more limited buyer pools
- Multiple ranges — cosmetic-heavy practices command premium multiples; medical-only practices operate at standard professional service ranges
- Methodology emphasis — cosmetic revenue valuation differs structurally from medical revenue valuation
- Operational preparation requirements — different succession paths require different operational preparation work
- Timeline considerations — cosmetic practice succession often operates on shorter horizons than medical practice succession
The American Academy of Dermatology's practice transitions resources cover the broader framework that dermatology practice owners operate within.
How The Cosmetic-Medical Revenue Mix Shapes Succession Options
The proportion of cosmetic versus medical revenue substantially shapes succession options for dermatology practice owners. The ratio affects buyer interest, applicable multiples, and the operational preparation that supports succession success.
Common cosmetic-medical mix patterns:
- Cosmetic-heavy practices (60%+ cosmetic revenue) — attract active private equity and dermatology consolidator interest; support premium multiples; succession paths typically include consolidator sales as primary option
- Balanced cosmetic-medical practices (30-60% cosmetic revenue) — attract moderate consolidator interest; multiples between cosmetic-heavy premiums and medical-only standards; succession paths include consolidator sales, associate succession, and individual practitioner buyers
- Medical-heavy practices (less than 30% cosmetic revenue) — limited consolidator interest in some markets; multiples at standard professional service ranges; succession paths typically emphasize associate succession or individual practitioner buyers
- Mohs surgery and surgical dermatology specialty — operates as distinct subspecialty with specialty-specific buyer dynamics
- Pediatric dermatology specialty — limited subspecialty practice with specialty-specific considerations affecting succession
Recent Barron's coverage of dermatology private equity activity documents the differential consolidator activity between cosmetic-heavy and medical-only dermatology segments.
How Dermatology Methodology Differs Across Practice Segments
Dermatology methodology varies meaningfully across cosmetic-heavy and medical-only practice segments. The differences affect every aspect of valuation work:
For cosmetic-heavy practices:
- Higher revenue multiples — typically 1.0 to 1.5 times revenue for solo practitioner buyers; 2.0+ times revenue for consolidator buyers
- Higher EBITDA multiples — typically 6 to 8 times EBITDA for tuck-in consolidator acquisitions; 8 to 12 times EBITDA for platform-quality practices
- Recurring service revenue analysis — emphasis on injectable treatment patterns, laser treatment retention, membership program revenue
- Treatment mix evaluation — emphasis on premium service mix (advanced laser, injectables, cosmetic procedures) versus commodity service mix
- Brand and reputation evaluation — strong emphasis on practice and provider brand recognition
For medical-only practices:
- Standard professional service multiples — typically 0.7 to 0.9 times revenue; 4 to 6 times EBITDA
- Payer mix analysis — strong emphasis on insurance contracts and payer relationships
- Patient panel analysis — emphasis on active patient count, retention patterns, referral source patterns
- Mohs surgery contribution — practices with substantial Mohs surgery revenue often receive premium consideration
- Pathology integration — practices integrating pathology services support additional value
The deeper coverage of EBITDA margin considerations that drive practice valuation walks through margin factors specific to professional service practices including dermatology.
Typical Dermatology Practice Multiples By Segment
Dermatology practice multiples vary substantially by segment and buyer category:
- Medical-only solo practice (individual buyer) — typically 60 to 80 percent of revenue or 3 to 5 times EBITDA
- Medical-only practice (smaller consolidator) — typically 5 to 7 times EBITDA
- Balanced cosmetic-medical (private equity platform) — typically 7 to 10 times EBITDA
- Cosmetic-heavy practice (private equity platform) — typically 8 to 14 times EBITDA
- Mohs surgery-heavy practice — typically supports premium multiples within the medical dermatology range
- Multi-location dermatology platform — typically supports the highest multiples reflecting platform-tier strategic value
The variation reflects substantial differences in buyer competition, growth prospects, and operational economics across segments.
How Recent Research Frames The Dermatology Succession Landscape
Recent Harvard Business Review research on private equity and physician practices provides analytical framework relevant to dermatology succession planning. The research patterns translate directly to dermatology contexts:
- Practices that prepare systematically for consolidator transactions produce materially better outcomes than practices entering transactions reactively
- Post-acquisition operational changes affect dermatology practices substantially; succession planning must address whether owner accepts those changes
- Multi-year preparation produces multiple-turn premiums on transition multiples
- Owner equity rollover requirements in private equity transactions affect total economic outcomes substantially
- Cultural fit between owner and consolidator platform shapes both transaction success and post-transaction performance
The research-grounded framework supports systematic dermatology succession preparation.
Common Dermatology Succession Path Considerations
Dermatology practice owners considering succession have several path options:
- Private equity platform sale — typically produces highest absolute valuation for cosmetic-heavy practices; requires accepting post-acquisition operational changes and equity rollover structures
- Dermatology consolidator acquisition — operates similarly to private equity platform sales with industry-specific operational integration emphasis
- Individual dermatologist buyer — produces clean exits at lower valuations; supports owner control over transition timing
- Associate succession — produces operational continuity at lower valuations; affordability compressed by consolidator multiple environment
- Family succession — when family members pursue dermatology careers; supports legacy considerations
- Practice split before sale — separating cosmetic and medical operations to optimize succession outcomes for each segment
The deeper coverage of the framework for multi-year practice succession planning walks through path selection considerations applicable across professional service industries including dermatology.
Multi-Year Preparation Specific To Dermatology Succession
Dermatology practice owners benefit substantially from multi-year succession preparation. Several specific operational levers shift succession outcomes when addressed early:
- Cosmetic service expansion — strategically expanding cosmetic service offerings to shift cosmetic-medical revenue mix toward premium-multiple territory
- Provider capacity development — recruiting and retaining associate dermatologists who reduce owner clinical dependence
- Practice management infrastructure — building practice management systems that support consolidator integration requirements
- Financial documentation depth — clean books, well-normalized financials, documented operational metrics
- Brand development — building practice-tied brand recognition beyond owner personal brand
- Multi-location preparation — for practices with platform aspirations, expanding to multiple locations builds platform-tier value
- Real estate optimization — securing favorable long-term lease positions or real estate ownership structures
The preparation work typically takes 3 to 7 years to produce material succession outcome improvements. Practice owners with multi-year horizons consistently produce substantially better outcomes than owners entering succession planning in the final 1 to 2 years before intended transition.
Conclusion
Dermatology practice succession planning requires understanding cosmetic-medical revenue mix considerations, active consolidator dynamics in the cosmetic segment, methodology calibrated to dermatology economics, and multi-year preparation horizons that produce strong succession outcomes. Practice owners who systematically prepare over multi-year horizons produce substantially better outcomes than owners entering succession reactively. The industry-specific calculators at PracticeValuationCalculators main page apply dermatology methodology at the early-research tier. Questions about dermatology succession planning can be sent through the contact page.